Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/03/1997 | WO1996037621A3 Multimeric proteins |
01/03/1997 | WO1996035717A3 Soluble, cleavable substrates of the hepatitis c virus protease |
01/03/1997 | WO1996034965A3 Chimeric mcp and daf proteins with cell surface localizing domain |
01/03/1997 | CA2361012A1 Conformationally-restricted combinatorial library composition and method |
01/03/1997 | CA2224976A1 New family of linear antimicrobial peptides from hagfish intestine |
01/03/1997 | CA2224723A1 Novel enhancer sequences for late t cell expressed genes |
01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
01/03/1997 | CA2224566A1 New cationic and polycationic amphiphiles, reagents containing them and their use |
01/03/1997 | CA2223792A1 Urocortin peptides |
01/03/1997 | CA2221981A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
01/03/1997 | CA2221647A1 Modified avidin and streptavidin molecules and use thereof |
01/02/1997 | EP0751225A1 Process for the identification of proteolytic activities and/or inhibitors thereof |
01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
01/02/1997 | EP0751220A1 Highly purified protein, production and use thereof |
01/02/1997 | EP0751219A1 Platelet aggregation inhibitors |
01/02/1997 | EP0751149A2 Phenylalanine substitution analogues of magainin peptides |
01/02/1997 | EP0751148A2 D-amino acid substitution analogues of Magainin peptides |
01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
01/02/1997 | EP0750743A1 Methods and devices for automatic assessment of corn |
01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
01/02/1997 | EP0750670A1 Compositions useful in controlling marek's disease |
01/02/1997 | EP0750669A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
01/02/1997 | EP0750667A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
01/02/1997 | EP0750665A1 cDNAs ENCODING MINOR AMPULLATE SPIDER SILK PROTEINS |
01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
01/02/1997 | EP0750636A1 Methods to diagnose and treat hiv-1 infection |
01/02/1997 | EP0750635A1 Peptides inhibiting the release of pepsine |
01/02/1997 | EP0750634A1 Enhanced secretion of polypeptides |
01/02/1997 | EP0750633A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
01/02/1997 | EP0750632A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
01/02/1997 | EP0750513A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
01/02/1997 | EP0750508A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins |
01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
01/02/1997 | EP0654081B1 Hypoglycosylated recombinant glucosidase oxidases |
01/02/1997 | EP0556345B1 Retroviral vectors useful for gene therapy |
01/02/1997 | EP0538341B1 Ehv-4 glycoprotein vaccine |
01/02/1997 | EP0532746B1 Assay for non-a non-b hepatitis |
01/02/1997 | EP0477295B1 Platelet aggregation inhibitors |
01/02/1997 | DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
01/02/1997 | DE19523935A1 Pumpvorrichtung Pumping device |
01/01/1997 | CN1139454A Antimicrobial proteins |
12/31/1996 | US5589624 Antifungal polypeptide and process for its production |
12/31/1996 | US5589622 Plant parasitic nematode control |
12/31/1996 | US5589620 Isolated from plants; useful in transforming vectors, host organisms and plants; produce plants which exhibit an increased resistance towards pests |
12/31/1996 | US5589616 Genetically engineered tobacco plant cells containing zein |
12/31/1996 | US5589615 Seed forming plant susceptible to agrobacterium |
12/31/1996 | US5589611 Disease resistance gene from maize and its use for disease resistance as a selectable marker and as a gene identification probe |
12/31/1996 | US5589610 Stamen-specific promoters from corn |
12/31/1996 | US5589585 DNA fragments, probes and amplification primers of the 65 kD antigen of mycobacteria |
12/31/1996 | US5589583 Plant promoter |
12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines |
12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
12/31/1996 | US5589572 Process for production of inhibited forms of activated blood factors |
12/31/1996 | US5589571 Process for production of inhibited forms of activated blood factors |
12/31/1996 | US5589570 Integrin alpha subunit cytoplasmic domain polypeptides and methods |
12/31/1996 | US5589568 Methods and compositions for modulating G protein action |
12/31/1996 | US5589466 Induction of a protective immune response in a mammal by injecting a DNA sequence |
12/31/1996 | US5589460 Modification of melanotrophic release inhibiting factor |
12/31/1996 | US5589459 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
12/31/1996 | US5589456 Dna and expression vectors |
12/31/1996 | US5589453 Viricides |
12/31/1996 | US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
12/31/1996 | US5589397 Method for monitoring the performance of an amino acid sequencer |
12/31/1996 | US5589386 Hydrolysis of cholinesterase inhibitors using parathion hydrolase |
12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes |
12/31/1996 | US5589382 Bacillus thuringiensis genes encoding nematode-active toxins |
12/31/1996 | US5589380 Isolated DNA molecule encoding SHET1 of Shigella flexneri 2a and mutant Shigella flexneri 2a |
12/31/1996 | US5589377 Cells and genetic engineering |
12/31/1996 | US5589375 Dephosphorylation |
12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
12/31/1996 | US5589371 Polypeptides and yeast expression vectors for culture |
12/31/1996 | US5589367 Recombinant plant viral nucleic acids |
12/31/1996 | US5589364 Genetic engineering with proteins for protease deficient microbial host transformed with expression vector having dna codes and gene expression |
12/31/1996 | US5589363 DNA encoding tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
12/31/1996 | US5589362 Fusion proteins, eukaryotic cells |
12/31/1996 | US5589360 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
12/31/1996 | US5589359 Chimeric proteins |
12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
12/31/1996 | US5589356 Cyclization |
12/31/1996 | US5589345 Leukemia cells |
12/31/1996 | US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes |
12/31/1996 | US5589341 Origin of replication complex genes and methods of using the same |
12/31/1996 | US5589340 Process and primers for identifying nucleic acids encoding A-lineage conotoxin peptides |
12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia |
12/31/1996 | US5589336 Diagnostic method and kit for determining Kell blood group genotype |
12/31/1996 | US5589334 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof |
12/31/1996 | US5589175 Vaccines against aids |